Publications list | EBMT

Top

Area

Group

Year

Disease

Text

Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper

Chronic Malignancies Working Party (CMWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Lymphoma Working Party (LWP)

Patient Advocacy Committee

Trainee Committee

Nursing Research Committee

Nursing Scientific Committee

1st listed author

Lancet Haematol.

Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

Acute Leukemia Working Party (ALWP)

1st listed author

Eleni Gavriilaki

Bone Marrow Transplant.

New insights in systemic lupus erythematosus: From regulatory T cells to CAR-T-cell strategies

Autoimmune Diseases Working Party (ADWP)

1st listed author

J Allergy Clin Immunol.

Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT

Acute Leukemia Working Party (ALWP)

1st listed author

Bone Marrow Transplant.

Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT

Acute Leukemia Working Party (ALWP)

1st listed author

Alexandros Spyridonidis

Bone Marrow Transplant.

Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modelling

Chronic Malignancies Working Party (CMWP)

1st listed author

STEM CELL TRANSPLANTATION IN PATIENTS AFFECTED BY SHWACHMAN- DIAMOND SYNDROME: EXPERT CONSENSUS AND RECOMMENDATIONS FROM THE EBMT SEVERE APLASTIC ANAEMIA WORKING PARTY

Severe Aplastic Anaemia Working Party (SAAWP)

1st listed author

Transplant Cell Ther.

Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)

Acute Leukemia Working Party (ALWP)

1st listed author

Bone Marrow Transplant.

The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency

Inborn Errors Working Party (IEWP)

1st listed author

Jerold Jeyaratnam

Pediatr Rheumatol Online J.

Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Acute Leukemia Working Party (ALWP)

1st listed author

Bone Marrow Transplant.

Impact of the addition of antithymocyte globulin to post-transplant cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplant cyclophosphamide alone in acute myeloid leukemia: a retrospective study on behalf of the Acute Leukemia Working Party of the EBMT

Acute Leukemia Working Party (ALWP)

1st listed author

Giorgia Battipaglia

Transplant Cell Ther.

Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation

Transplant Complications Working Party (TCWP)

1st listed author

Bone Marrow Transplant.